PMID: 9532585Apr 9, 1998Paper

Multiple sclerosis: IL-2 and sIL-2R levels in cerebrospinal fluid and serum. Review of literature and critical analysis of ELISA pitfalls

Multiple Sclerosis : Clinical and Laboratory Research
S SivieriP Gallo

Abstract

The presence of interleukin-2 (IL-2) and soluble IL-2 receptors (sIL-2R) in the serum and cerebrospinal fluid (CSF) of patients suffering from multiple sclerosis (MS) has been extensively investigated. These studies, however, have produced conflicting results. The only significant finding concerns the frequent detection of increased sIL-2R levels in the serum in patients with relapsing-remitting MS (RRMS), especially after a short interval of time from the last relapse. Whether this finding can be used for clinical purposes requires further investigation. A standardization of the ELISA methods used to detect cytokines in biological fluids is urgently needed. Increased serum and/or CSF levels of IL-2 and sIL-2R strongly confirm a CD4+ Th1 activation.

References

Feb 1, 1991·Journal of the Neurological Sciences·P GalloA Sidén
Feb 1, 1993·Journal of Neurology, Neurosurgery, and Psychiatry·M K Sharief, E J Thompson
Feb 26, 1993·Journal of Immunological Methods·T JungC Rieger

❮ Previous
Next ❯

Citations

Jul 13, 2013·Multiple Sclerosis : Clinical and Laboratory Research·Y ZhangJ P Sheridan
Jan 19, 2021·Experimental Eye Research·S A Espírito-SantoP Campello-Costa

❮ Previous
Next ❯

Related Concepts

Related Feeds

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.